Health · 1 sources covering this

STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

After the failure of an experimental drug for Angelman syndrome, experts cautioned that there is still reason to think similar experimental medicines can succeed.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
After the failure of an experimental drug for Angelman syndrome, experts cautioned that there is still reason to think similar experimental medicines can succeed.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/316597e694822664c66d37d39054d9c7d6b3f747"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies"></iframe>

STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

How 1 sources are covering this

STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

More from Health

Not a mistrial, yet. Clancy's lawyer asks for emergency appeal in her murder trial

STAT+: Top Boston hospitals clash over Medicare Advantage network after split

STAT+: FDA takes another look at botanical drugs

Disabled workers at greater risk of losing health insurance

Reader

Trust & legal

Across the network